Exploring the anti-inflammatory activities, mechanism of action and prospective drug delivery systems of tocotrienol to target neurodegenerative diseases
Open Access
- 27 March 2023
- journal article
- review article
- Published by F1000 Research Ltd in F1000Research
- Vol. 12, 338
Abstract
A major cause of death in the elderly worldwide is attributed to neurodegenerative diseases, such as AD (Alzheimer’s disease), PD (Parkinson’s disease), ALS (Amyotrophic lateral sclerosis), FRDA (Friedreich’s ataxia), VaD (Vascular dementia) etc. These can be caused due to multiple factors such as genetic, physiological problems like stroke or tumor, or even external causes like viruses, toxins, or chemicals. T3s (tocotrienols) exhibit various bioactive properties where it acts as an antioxidant, anti-inflammatory, anti-tumorigenic, and cholesterol lowering agent. Since T3 interferes with and influences several anti-inflammatory mechanisms, it aids in combating inflammatory responses that lead to disease progression. T3s are found to have a profound neuroprotective ability, however, due to their poor oral bioavailability, their full potential could not be exploited. Hence there is a need to explore other drug delivery techniques, especially focusing on aspects of nanotechnology. In this review paper we explore the anti-inflammatory mechanisms of T3 to apply it in the treatment of neurodegenerative diseases and also discusses the possibilities of nano methods of administering tocotrienols to target neurodegenerative diseases.Keywords
This publication has 94 references indexed in Scilit:
- γ-tocotrienol attenuates TNF-α-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytesMolecular Medicine Reports, 2012
- Dietary Supplementation with Tocotrienols Enhances Immune Function in C57BL/6 MiceThe Journal of Nutrition, 2010
- Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female miceLipids in Health and Disease, 2010
- Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary diseaseScandinavian Journal of Clinical and Laboratory Investigation, 2009
- Osteoporosis and InflammationNutrition Reviews, 2007
- Neuroprotective Properties of the Natural Vitamin E α-TocotrienolStroke, 2005
- TOCOTRIENOL OFFERS BETTER PROTECTION THAN TOCOPHEROL FROM FREE RADICAL‐INDUCED DAMAGE OF RAT BONEClinical and Experimental Pharmacology and Physiology, 2005
- Inflammation and cancerNature, 2002
- Inflammation in atherosclerosisNature, 2002
- Inflammation and Alzheimer’s Disease: Mechanisms and Therapeutic StrategiesGerontology, 1997